Trial intelligence / Profile preview

Adrenaline infusion and inflammatory response in type 1 diabetes and healthy participants

NL-OMON53203Completed

Sponsor
Radboud University Medical Center
Start
Nov 2023
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of epinephrine (2 cohorts), sponsored by Radboud University Medical Center. Started Nov 2023; status: completed.

02

Drugs

epinephrine

Beyond the preview

Go deeper on NL-OMON53203.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON53203.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call